Is the combination of calcipotriol and PUVA effective in vitiligo?

Journal of the European Academy of Dermatology and Venereology

Volumn 17, Issue 3, 2003, Pages 299-302

  Baysal, V ^a   Yildirim, M ^a   Erel, A ^b   Kesici, D ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

Author keywords

Calcipotriol; PUVA; Treatment; Vitiligo

Indexed keywords

CALCIPOTRIOL; PSORALEN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ERYTHEMA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PRURITUS; PUVA; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VITILIGO; XEROSIS;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; AGED; CALCITRIOL; COMBINED MODALITY THERAPY; DERMATOLOGIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PUVA THERAPY; TREATMENT OUTCOME; VITILIGO;

EID: 0038363553     PISSN: 09269959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-3083.2003.00795.x     Document Type: Article

References (11)

1. Vaquez-Lopez F, Perez Olivia N. Transient hyperpigmentation after calcipotriol and PUVA therapy in psoriatic patients. Acta Derm-Venereol 1996; 76: 400.
2. Kokelj F, Lavaroni G, Perkan V, Plazzer C. Hyperpigmentation due to calcipotriol (MC 903) plus heliotherapy in psoriatic patients. Acta Derm-Venereol (Stockh) 1995; 75: 307-309.
3. Glaser R, Rowert J, Mrowietz U. Hyperpigmentation due to topical calcipotriol and photochemotherapy in two psoriatic patients. Br J Dermatol 1998; 197: 167-170.
4. Mosher DB, Fitzpatrick TB, Ortonne JP, Hori Y. Hypomelanoses and hypermelanoses. In: Freedberg IM, Eisen Az, Wolff K et al., eds. Dermatology in General Medicine, 5th edn. McGraw Hill, New York, 1999: 949-960.
5. Njoo MD, Westerhof W. Vitiligo. Pathogenesis and treatment. Am J Clin Dermatol 2001; 2 (3): 167-181.
6. Jimbow K. Vitiligo. Therapeutic advances. Dermatol Clin 1998; 16 (2): 399-407.
7. Yalcin B, Sahin S, Bukulmez G et al. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. J Am Acad Dermatol 2001; 44: 634-637.
8. Ameen M, Exarchov V, Chu AC. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo. Br J Dermatol 2001; 145: 476-479.
9. Ermis O, Alpsoy E, Cetin L, Yilmaz E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001; 145: 472-475.
10. Parsad D, Saini R, Verma N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998; 197: 167-170.
11. Parsad D, Saini R, Nagpal R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999; 16: 317-320.